Published in J Psychiatr Res on November 11, 2009
Fludrocortisone and Information Processing in Healthy Volunteers | NCT01648998
Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology (2011) 1.09
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) (2012) 1.04
A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology (2011) 0.94
A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry (2011) 0.89
Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology (2012) 0.88
Cortisol's effects on hippocampal activation in depressed patients are related to alterations in memory formation. J Psychiatr Res (2011) 0.87
Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology (2014) 0.86
The multifaceted mineralocorticoid receptor. Compr Physiol (2014) 0.85
The ubiquitous mineralocorticoid receptor: clinical implications. Curr Hypertens Rep (2012) 0.85
The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology (2012) 0.84
Genetic Moderation of Stress Effects on Corticolimbic Circuitry. Neuropsychopharmacology (2015) 0.84
The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology (2010) 0.83
Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth? J Cardiovasc Pharmacol (2016) 0.80
Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule? Trends Endocrinol Metab (2011) 0.79
Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist. Front Psychiatry (2014) 0.79
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis. Steroids (2014) 0.78
Metyrapone in treatment-resistant depression. Ther Adv Psychopharmacol (2012) 0.77
Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review. Ann Behav Med (2016) 0.77
HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry (2016) 0.75
Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat (2017) 0.75
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest (2003) 3.62
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Posttraumatic stress disorder and memory problems after female genital mutilation. Am J Psychiatry (2005) 1.75
Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry (2003) 1.73
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry (2004) 1.63
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry (2002) 1.56
Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Psychopharmacology (Berl) (2002) 1.49
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem (2007) 1.28
Heritability of sleep electroencephalogram. Biol Psychiatry (2008) 1.19
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res (2005) 1.18
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol (2006) 1.17
Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry (2011) 1.14
Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia. Arch Clin Neuropsychol (2002) 1.14
Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis (2005) 1.12
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging (2007) 1.10
The contribution of a cognitive bias against disconfirmatory evidence (BADE) to delusions in schizophrenia. J Clin Exp Neuropsychol (2006) 1.08
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord (2009) 1.08
Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry (2009) 1.07
Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab (2007) 1.07
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One (2011) 1.07
Are obese adolescents and young adults at higher risk for mental disorders? A community survey. Obes Res (2002) 1.05
Dissociation as a predictor of cognitive behavior therapy outcome in patients with obsessive-compulsive disorder. Psychother Psychosom (2006) 1.04
Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res (2006) 1.01
Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment? Biol Psychiatry (2006) 1.01
Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS One (2010) 1.01
Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress (2011) 1.01
Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology (2006) 1.00
Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology (2009) 0.99
Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis (2010) 0.96
Do personality disorders predict negative treatment outcome in obsessive-compulsive disorders? A prospective 6-month follow-up study. Eur Psychiatry (2005) 0.96
The facial pattern of disgust, appetence, excited joy and relaxed joy: an improved facial EMG study. Scand J Psychol (2005) 0.95
The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives. Int J Geriatr Psychiatry (2008) 0.95
Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res (2005) 0.93
Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. J Psychiatr Res (2006) 0.93
Belief inflexibility in schizophrenia. Cogn Neuropsychiatry (2008) 0.92
The effect of state anxiety on paranoid ideation and jumping to conclusions. An experimental investigation. Schizophr Bull (2009) 0.92
Central serotonin transporter levels are associated with stress hormone response and anxiety. Psychopharmacology (Berl) (2010) 0.92
Optimization of 3-dimensional imaging of the breast region with 3-dimensional laser scanners. Ann Plast Surg (2006) 0.92
Depressive syndromes in neurological disorders. Eur Arch Psychiatry Clin Neurosci (2013) 0.91
Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients. Schizophr Res (2002) 0.91
Childhood trauma and dissociation in female patients with schizophrenia spectrum disorders: an exploratory study. J Nerv Ment Dis (2006) 0.91
The EVIDENT-trial: protocol and rationale of a multicenter randomized controlled trial testing the effectiveness of an online-based psychological intervention. BMC Psychiatry (2013) 0.91
Sleep disturbances in highly stress reactive mice: modeling endophenotypes of major depression. BMC Neurosci (2011) 0.91
Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2012) 0.90
Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology (2011) 0.90
The organization of autobiographical and nonautobiographical memory in posttraumatic stress disorder (PTSD). J Abnorm Psychol (2009) 0.90
Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology (Berl) (2002) 0.90
Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J Behav Ther Exp Psychiatry (2010) 0.90
Verbal and nonverbal memory functioning in posttraumatic stress disorder (PTSD). J Clin Exp Neuropsychol (2006) 0.90
Impact of childhood trauma on hypothalamus-pituitary-adrenal axis activity in alcohol-dependent patients. Eur Addict Res (2010) 0.90
Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J Clin Psychopharmacol (2003) 0.89
Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Mov Disord (2002) 0.89
Use of proteomic methods in the analysis of human body fluids in Alzheimer research. Electrophoresis (2012) 0.89
Association of leptin with food cue-induced activation in human reward pathways. Arch Gen Psychiatry (2012) 0.89
Emotional valence and semantic relatedness differentially influence false recognition in mild cognitive impairment, Alzheimer's disease, and healthy elderly. J Int Neuropsychol Soc (2009) 0.88
The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology (2011) 0.88
A bias against disconfirmatory evidence is associated with delusion proneness in a nonclinical sample. Schizophr Bull (2007) 0.88
Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J Gerontol A Biol Sci Med Sci (2003) 0.88
Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res (2011) 0.88
Words may not be enough! No increased emotional Stroop effect in obsessive-compulsive disorder. Behav Res Ther (2008) 0.88
The contribution of a cognitive bias against disconfirmatory evidence (BADE) to delusions: a study in an Asian sample with first episode schizophrenia spectrum disorders. Schizophr Res (2006) 0.88
An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology (2011) 0.88
Ghrelin levels increase after pictures showing food. Obesity (Silver Spring) (2012) 0.87
Heart rate variability in response to affective scenes in posttraumatic stress disorder. Biol Psychol (2011) 0.87
Dimensional structure of the Hamilton Depression Rating Scale in patients with obsessive-compulsive disorder. Psychiatry Res (2004) 0.87
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology (Berl) (2004) 0.87
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide. Neuropeptides (2003) 0.87
Association between childhood trauma and low hair cortisol in depressed patients and healthy control subjects. Biol Psychiatry (2013) 0.86
Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology (2011) 0.86
Cortisol response to experimental pain in patients with chronic low back pain and patients with major depression. Pain Med (2012) 0.86
Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol (2005) 0.86
Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study. Schizophr Bull (2013) 0.86
"Don't give me that look" - overconfidence in false mental state perception in schizophrenia. Psychiatry Res (2012) 0.85
Sex differences of salivary cortisol secretion in patients with major depression. Stress (2011) 0.85
What happened to the voices? A fine-grained analysis of how hallucinations and delusions change under psychiatric treatment. Psychiatry Res (2011) 0.85
Increased DHEA and DHEA-S plasma levels in patients with post-traumatic stress disorder and a history of childhood abuse. J Psychiatr Res (2009) 0.85